Home > Analytics > TITAN BIOTECH

TITAN BIOTECH
Intrinsic Value | Fundamental Analysis

BOM : 524717     NSE :     
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Feb 07,2023
Price(EOD): ₹ 241.10
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Chemicals
MCap: ₹ 200.11 Cr
Value of ₹ 1 Lac invested in TITAN BIOTECH
on Feb 07,2018 (price: ₹ 63.75)

₹ 1 L

₹ 3.78 L

1W : -15.3% 1M : -15.5% 1Y : -23.5%
COMMUNITY POLL
for TITAN BIOTECH
Please provide your vote to see the results
TITAN BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Industry Peers & Returns1W1M1Y
TITAN BIOTECH -15.3% -15.5% -23.5%
PIDILITE INDUSTRIES 0.1% -8.2% -6.8%
SOLAR INDUSTRIES (INDIA) -2% -11.9% 67.2%
GUJARAT FLUOROCHEMICALS 1.8% -5.2% -10.3%
DEEPAK NITRITE -3.9% -8.3% -22.4%
TATA CHEMICALS 7.7% 8.7% 4.1%
ATUL 0.2% -8.4% -23.9%
AARTI INDUSTRIES 1% -10.9% -43.2%
NAVIN FLUORINE INTERNATIONAL 7.3% 10.7% -0.2%

FUNDAMENTAL ANALYSIS OF TITAN BIOTECH

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 TITAN BIOTECH is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF TITAN BIOTECH

 
Valuation Score
[As on : Feb 07,2023 ]

Ratio Consolidated
P/E
P/B
P/S
9.25
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 21.53 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

2.14
P/B Calculated based on Book Value of Rs 93.03 Cr
[Latest Year - Mar2022 - Consolidated Results ]

1.42
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 140.10 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 29% undervalued companies ! Discover More →

FAIR VALUE OF TITAN BIOTECH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-21%
80%
115%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF TITAN BIOTECH



TITAN BIOTECH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF TITAN BIOTECH

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.09
0.13
0.47
0.23
0.2
0.21
0.61
0.34
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF TITAN BIOTECH

Pledged Promoter Shares
0 %
As on : Dec2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF TITAN BIOTECH

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-27.49%
-60.52%
-65.55%
-65.81%
-16.73%
-52.39%
-54.41%
-54.53%
QtrlyTrend
-8
Latest Qtr: Dec2022
Quarterly Result Analysis →


TITAN BIOTECH related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about TITAN BIOTECH


Is TITAN BIOTECH good for long term investment?

As on Feb 07,2023, the Fundamentals of TITAN BIOTECH look Strong and hence it may be good for long term investment! See Financial Performance of TITAN BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is TITAN BIOTECH UnderValued or OverValued?

As on Feb 07,2023, TITAN BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of TITAN BIOTECH ?

As on Feb 07,2023, the Intrinsic Value of TITAN BIOTECH is Rs. 134.30 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 305.05
Fair Value [Median EV / Sales Model] : Rs. 134.30
Fair Value [Median Price / Sales Model] : Rs. 112.36
Estimated Median Fair Value of TITAN BIOTECH : Rs. 134.30

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is TITAN BIOTECH trading at a Premium or Discount?

As on Feb 07,2023, TITAN BIOTECH is trading at a Premium of 80% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].